This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Mayne Pharma LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kevin Warner: Innovator in Stabilized Oxymetazoline Formulations
Introduction
Kevin Warner is a notable inventor based in Anaheim, California. He has made significant contributions to the field of pharmaceutical formulations, particularly with his innovative work on stabilized oxymetazoline formulations.
Latest Patents
Warner holds a patent for "Stabilized oxymetazoline formulations and their uses." This invention provides stabilized cream formulations of oxymetazoline, which are designed to treat facial erythema associated with rosacea. The method involves topically administering a pharmaceutical composition containing 0.5%, 1.0%, or 1.5% oxymetazoline to the affected area on the face of patients in need of treatment.
Career Highlights
Throughout his career, Warner has worked with various companies, including Mayne Pharma LLC and Epi Health, LLC. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Warner has collaborated with professionals such as Pramod Sarpotdar and Steven Zhang, enhancing his work through shared knowledge and expertise.
Conclusion
Kevin Warner's contributions to the field of stabilized oxymetazoline formulations highlight his innovative spirit and dedication to improving patient care. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile